These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7854192)

  • 21. Autoprocessing: an essential step for the activation of HIV-1 protease.
    Wan M; Takagi M; Loh BN; Xu XZ; Imanaka T
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):569-73. PubMed ID: 8687402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes.
    Lindhofer H; von der Helm K; Nitschko H
    Virology; 1995 Dec; 214(2):624-7. PubMed ID: 8553565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and frameshifting but extremely inefficient proteolytic processing of the HIV-1 gag and pol gene products in stably transfected rodent cell lines.
    Moosmayer D; Reil H; Ausmeier M; Scharf JG; Hauser H; Jentsch KD; Hunsmann G
    Virology; 1991 Jul; 183(1):215-24. PubMed ID: 2053281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro inhibition of HIV-1 proteinase by cerulenin.
    Moelling K; Schulze T; Knoop MT; Kay J; Jupp R; Nicolaou G; Pearl LH
    FEBS Lett; 1990 Feb; 261(2):373-7. PubMed ID: 1690152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics analysis of consecutive HIV proteolytic cleavages of the Gag-Pol polyprotein.
    Rasnick D
    J Biol Chem; 1997 Mar; 272(10):6348-53. PubMed ID: 9045655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic approaches designed to minimize cytotoxicity of retroviral protease.
    Rizzo CJ; Korant BD
    Methods Enzymol; 1994; 241():16-29. PubMed ID: 7854177
    [No Abstract]   [Full Text] [Related]  

  • 29. An E. coli expression system which detoxifies the HIV protease.
    Korant BD; Rizzo CJ
    Biomed Biochim Acta; 1991; 50(4-6):643-6. PubMed ID: 1801736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope-based assay to determine the efficiency of cleavage by HIV-1 protease.
    Serio D; Weber IT; Harrison RW; Louis JM; Srinivasan A
    Biotechniques; 1999 Feb; 26(2):242-4, 246. PubMed ID: 10023533
    [No Abstract]   [Full Text] [Related]  

  • 31. Human immunodeficiency virus type 1 and type 2 protease monomers are functionally interchangeable in the dimeric enzymes.
    Patterson CE; Seetharam R; Kettner CA; Cheng YS
    J Virol; 1992 Feb; 66(2):1228-31. PubMed ID: 1731102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the protease gene of equine infectious anemia virus in Escherichia coli: formation of the mature processed enzyme and specific cleavage of the gag precursor.
    Rushlow K; Peng XX; Montelaro RC; Shih DS
    Virology; 1992 May; 188(1):396-401. PubMed ID: 1314466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoprocessing of the human immunodeficiency virus type 1 protease precursor expressed in Escherichia coli from a synthetic gene.
    Valverde V; Lemay P; Masson JM; Gay B; Boulanger P
    J Gen Virol; 1992 Mar; 73 ( Pt 3)():639-51. PubMed ID: 1545221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning, expression and purification of a recombinant poly-histidine-linked HIV-1 protease.
    Leuthardt A; Roesel JL
    FEBS Lett; 1993 Jul; 326(1-3):275-80. PubMed ID: 8325379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro processing of HIV-1 nucleocapsid protein by the viral proteinase: effects of amino acid substitutions at the scissile bond in the proximal zinc finger sequence.
    Tözsér J; Shulenin S; Louis JM; Copeland TD; Oroszlan S
    Biochemistry; 2004 Apr; 43(14):4304-12. PubMed ID: 15065874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
    Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH
    J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence-specific resonance assignments of the 1H-NMR spectra and structural characterization in solution of the HIV-1 transframe protein p6.
    Beissinger M; Paulus C; Bayer P; Wolf H; Rösch P; Wagner R
    Eur J Biochem; 1996 Apr; 237(2):383-92. PubMed ID: 8647076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli.
    Kräusslich HG; Schneider H; Zybarth G; Carter CA; Wimmer E
    J Virol; 1988 Nov; 62(11):4393-7. PubMed ID: 3050149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HIV-1 gag precursor is processed via two pathways: implications for cytotoxicity.
    Kaplan AH; Swanstrom R
    Biomed Biochim Acta; 1991; 50(4-6):647-53. PubMed ID: 1801737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.